Lisa Blackwell
Senior Statistical Programmer
- Vascular Overviews Group/Renal Studies Group
Lisa is a Senior Statistical Programmer at the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU). She completed her degree in Applied Statistics at the University of Plymouth, and is now the statistical programming lead for the ATT (Anti-Thrombotic Trialists’ Collaboration), CTT (Cholesterol Treatment Trialists’ Collaboration) and STT (Stroke Thrombolysis Trialists’ Collaboration) projects within the CTSU’s Vascular Overviews Group. She is a member of the teaching staff for the Principles of Statistics module for the Nuffield Department of Population Health Global Health Science MSc. Her research interests focus on cardiovascular disease and large-scale individual participant meta-analyses of randomised studies.
Recent publications
-
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.
Journal article
Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet, 400, 832 - 845
-
Individual participant data meta-analysis of muscle symptoms in large-scale randomised double-blind trials of statin therapy
Journal article
BAIGENT C. et al, (2022), The Lancet
-
Harmonisation of large-scale, heterogeneous individual participant adverse event data from randomised trials of statin therapy.
Journal article
Cholesterol Treatment Trialists' Collaboration None., (2022), Clin Trials
-
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials.
Journal article
Cholesterol Treatment Trialists' Collaboration None., (2019), Lancet, 393, 407 - 415
-
Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial.
Journal article
3C Study Collaborative Group None., (2018), Am J Transplant, 18, 1424 - 1434
-
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials.
Journal article
Hacke W. et al, (2018), Int J Stroke, 13, 175 - 189
-
Interpretation of the evidence for the efficacy and safety of statin therapy.
Journal article
Collins R. et al, (2016), Lancet, 388, 2532 - 2561
-
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.
Journal article
Cholesterol Treatment Trialists' (CTT) Collaboration None. et al, (2016), Lancet Diabetes Endocrinol, 4, 829 - 839
-
Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.
Journal article
Lees KR. et al, (2016), Stroke, 47, 2373 - 2379
-
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis.
Journal article
Whiteley WN. et al, (2016), Lancet Neurol, 15, 925 - 933